These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1940375)
21. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875 [TBL] [Abstract][Full Text] [Related]
22. Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from Plasmodium falciparum. Kara U; Pye D; Lord R; Pam C; Gould H; Geysen M; Jones G; Stenzel D; Kidson C; Saul A J Immunol; 1989 Aug; 143(4):1334-9. PubMed ID: 2473129 [TBL] [Abstract][Full Text] [Related]
23. Lack of Ir gene control in the immune response to malaria. I. A thymus-independent antibody response to the repetitive surface protein of sporozoites. Schofield L; Uadia P J Immunol; 1990 Apr; 144(7):2781-8. PubMed ID: 2138652 [TBL] [Abstract][Full Text] [Related]
24. Induction of antibodies against the Plasmodium falciparum p126 antigen in non-responder H-2b and partial-responder H-2d mice using synthetic peptides. Gilardeau Truffinet M; Bossus M; Camus D; Delplace P; Mazingue C; Diesis E; Tartar A; Moreau S; Gras-Masse H; Banic DM Pept Res; 1996; 9(2):61-70. PubMed ID: 8738980 [TBL] [Abstract][Full Text] [Related]
27. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175. Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929 [TBL] [Abstract][Full Text] [Related]
28. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. Udhayakumar V; Anyona D; Kariuki S; Shi YP; Bloland PB; Branch OH; Weiss W; Nahlen BL; Kaslow DC; Lal AA J Immunol; 1995 Jun; 154(11):6022-30. PubMed ID: 7538540 [TBL] [Abstract][Full Text] [Related]
29. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa. Dobaño C; Doolan DL Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242 [TBL] [Abstract][Full Text] [Related]
30. [Use of synthetic carriers and adjuvants for increasing the immunogenicity of a synthetic peptide from the CS-protein of Plasmodium falciparum]. Ivanov BB; Meshcheriakova EA; Andronova TM; Ivanov VT Bioorg Khim; 1991 Jun; 17(6):732-46. PubMed ID: 1723268 [TBL] [Abstract][Full Text] [Related]
31. Adjuvant poly(N-isopropylacrylamide) generates more efficient monoclonal antibodies against truncated recombinant histidine-rich protein2 of Plasmodium falciparum for malaria diagnosis. Verma R; Ravichandran R; Jayaprakash NS; Kumar A; Vijayalakshmi MA; Venkataraman K Biotechnol J; 2015 May; 10(5):772-82. PubMed ID: 25641957 [TBL] [Abstract][Full Text] [Related]
32. High-titer antisera production using three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2. Jones GL; Spencer L; Lord R; Edmundson H; Saul AJ Pept Res; 1991; 4(3):138-41. PubMed ID: 1823184 [TBL] [Abstract][Full Text] [Related]
33. Role of intrastructural/intermolecular help in immunization with peptide-phospholipid complexes. Goodman-Snitkoff G; Good MF; Berzofsky JA; Mannino RJ J Immunol; 1991 Jul; 147(2):410-5. PubMed ID: 1712806 [TBL] [Abstract][Full Text] [Related]
35. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2. Jones GL; Spencer L; Lord R; Saul AJ Vaccine; 1996 Jan; 14(1):77-84. PubMed ID: 8821653 [TBL] [Abstract][Full Text] [Related]
36. [Antigenic diversity of asexual schizont antigen GP195 of Plasmodium falciparum isolates from China]. Miao WM; Guan WB; Pang WQ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(2):110-3. PubMed ID: 1714800 [TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum: induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants. Hui GS; Chang SP Exp Parasitol; 1992 Aug; 75(1):155-7. PubMed ID: 1639161 [No Abstract] [Full Text] [Related]
38. Comparing Antibody Responses in Chickens Against Plasmodium falciparum Lactate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase with Freund's and Pheroid® Adjuvants. Krause RG; Grobler AF; Goldring JP Immunol Invest; 2015; 44(7):627-42. PubMed ID: 26436851 [TBL] [Abstract][Full Text] [Related]
39. Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum. Chang SP; Hui GS; Kato A; Siddiqui WA Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6343-7. PubMed ID: 2668963 [TBL] [Abstract][Full Text] [Related]
40. Influence of immunoadjuvants and a promiscous T-cell determinant on the immunogenicity of RESA peptide antigen of P. falciparum. Chaba B; Kumar P; Haq W; Sabhnani L; Rao DN Int J Immunopharmacol; 1998 Jun; 20(6):259-73. PubMed ID: 9754674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]